David Fitchett
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
Papers in
-
- Acute Myocardial Infarction Research 39
- Cardiovascular Function and Risk Factors 20
- Antiplatelet Therapy and Cardiovascular Diseases 15
-
- Diabetes Treatment and Management 82
- Co-authors
- Bernard Zinman (65 shared papers)Silvio E. Inzucchi (48 shared papers)Christoph Wanner (47 shared papers)Odd Erik Johansen (17 shared papers)John M. Lachin (10 shared papers)Uli C. Broedl (9 shared papers)Michaela Mattheus (26 shared papers)Stefan Hantel (19 shared papers)
- Journals
- Canadian Journal of Cardiology (33 papers)American Heart Journal (15 papers)The American Journal of Cardiology (15 papers)European Heart Journal (12 papers)Journal of the American College of Cardiology (8 papers)
- Partner nations
- CanadaGermanyUnited States
In The Last Decade
David Fitchett
192 papers receiving 18.4k citations
David Fitchett's Hit Papers
Peers
Comparison fields: 5 of 148
- Endocrinology, Diabetes and Metabolism 11.2k
- Cardiology and Cardiovascular Medicine 4.4k
- Nephrology 1.4k
- Surgery 4.6k
- Pharmacology 1.1k
Countries citing papers authored by David Fitchett
This map shows the geographic impact of David Fitchett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fitchett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fitchett more than expected).
Fields of papers citing papers by David Fitchett
This network shows the impact of papers produced by David Fitchett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fitchett. The network helps show where David Fitchett may publish in the future.
Co-authors
The 25 scholars most cited alongside David Fitchett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 202 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Hit paper breakdown → | 2015 | 8368 |
| 2 | Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Hit paper breakdown → | 2016 | 2624 |
| 3 | Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus Hit paper breakdown → | 2016 | 979 |
| 4 | How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial Hit paper breakdown → | 2017 | 534 |
| 5 | Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease Hit paper breakdown → | 2019 | 392 |
| 6 | 2015 | 294 | |
| 7 | Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial Hit paper breakdown → | 2019 | 252 |
| 8 | 2016 | 191 | |
| 9 | 2007 | 190 | |
| 10 | 2017 | 187 | |
| 11 | 2014 | 175 | |
| 12 | Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. | 1999 | 167 |
| 13 | 2011 | 142 | |
| 14 | 2003 | 140 | |
| 15 | 2006 | 138 | |
| 16 | 2013 | 133 | |
| 17 | 2018 | 126 | |
| 18 | 2007 | 126 | |
| 19 | 2013 | 115 | |
| 20 | 2020 | 109 |
About David Fitchett
David Fitchett is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 202 papers that have together received 19.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (82 papers), Acute Myocardial Infarction Research (39 papers), Pancreatic function and diabetes (24 papers), Metabolism, Diabetes, and Cancer (21 papers), Cardiovascular Function and Risk Factors (20 papers), Cardiac Imaging and Diagnostics (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers) and Coronary Interventions and Diagnostics (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (11.2k citations), Cardiology and Cardiovascular Medicine (4.4k citations), Nephrology (1.4k citations), Surgery (4.6k citations) and Pharmacology (1.1k citations). David Fitchett has collaborated with scholars based in Canada, Germany and United States. Frequent co-authors include Bernard Zinman, Silvio E. Inzucchi, Christoph Wanner, Odd Erik Johansen, John M. Lachin, Uli C. Broedl, Michaela Mattheus, Stefan Hantel, Erich Bluhmki and Hans J. Woerle. Their work appears in journals such as Canadian Journal of Cardiology, American Heart Journal, The American Journal of Cardiology, European Heart Journal and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.